Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $1.06 Million - $1.35 Million
22,536 New
22,536 $1.11 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $1.3 Million - $1.54 Million
-22,781 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $1.46 Million - $1.63 Million
22,781 New
22,781 $1.54 Million
Q4 2020

Feb 16, 2021

SELL
$43.41 - $56.51 $1.02 Million - $1.33 Million
-23,461 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$47.43 - $60.75 $1.11 Million - $1.43 Million
23,461 New
23,461 $1.14 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.